Skip to main content
Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

New TYK2 Inhibitors for Psoriasis Achieve High Clearance Rates in Randomized Trials

New TYK2 Inhibitors for Psoriasis Achieve High Clearance Rates in Randomized Trials
ShareXFacebook

(MedPage Today) -- DENVER -- Two drug candidates to expand oral therapy options for psoriasis had similar and consistent performances in separate phase III clinical trials reported here. The allosteric TYK2 inhibitor zasocitinib achieved at...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Do AI Scribes Actually Save Doctors Time?
MedPage Today

Do AI Scribes Actually Save Doctors Time?

(MedPage Today) -- Use of artificial intelligence (AI)-enabled ambient documentation tools, or AI scribes, was associated with modest decreases in time spent in the electronic health record (EHR) and documentation time, a multisite study suggested...

Read more →
Advertisement